Clinical Trial Update: A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Keluo Xin Capsule to placebo in patients with moderately severe to severe nonproliferative diabetic retinopathy; trial status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Nonproliferative Diabetic Retinopathy

Drugs mentioned

• Keluo Xin Capsule

Snippet

Sponsor: Chengdu Kanghong Pharmaceutical Co., Ltd. | Conditions: Moderately Severe to Severe NPDR | Phase 2 | Status: UNKNOWN